409 related articles for article (PubMed ID: 9878219)
1. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
[TBL] [Abstract][Full Text] [Related]
2. [Microscopic quantification of fluorescein distribution in retinas of normal and diabetic rats].
Proença D; Proença RD; Cunha-Vaz JG
J Fr Ophtalmol; 1990; 13(10):489-91. PubMed ID: 2081838
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
4. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
5. Calcein fluorophotometry in streptozocin-induced diabetic rats.
Golshani MR; Khoobehi B; Peyman GA; Aras C
Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
[TBL] [Abstract][Full Text] [Related]
6. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
[TBL] [Abstract][Full Text] [Related]
7. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.
Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
Mediators Inflamm; 2000; 9(5):243-8. PubMed ID: 11200365
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
10. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
11. Estimation of permeability in blood-retinal barrier.
Kojima M; Yoshida A; Ishiko S; Tanaka K
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
13. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
Moldow B; Sander B; Larsen M; Lund-Andersen H
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
15. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
16. Blood-retinal barriers in health and disease.
Cunha-Vaz JG
Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):337-40. PubMed ID: 6946626
[TBL] [Abstract][Full Text] [Related]
17. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
